People_
Dr Dannel Yeo
Adjunct Lecturer
School of Medical Sciences
Faculty of Medicine and Health
School of Medical Sciences
Faculty of Medicine and Health
Email
Dr Dannel Yeo (PhD) is a Lab Head and Senior Research Officer at Centenary Institute, an adjunct Senior Lecturer at The University of Sydney (School of Medical Science, Faculty of Medicine and Health), and honorary Hospital Research Scientist at Royal Prince Alfred, SLHD (Department of Cell and Molecular Therapies).
Dr Yeo is interested in understanding the biology of cancer for therapeutic intervention and improving patient management, focusing mainly in rare cancers such as pancreatic cancer and mesothelioma. His research areas include biomarkers, cellular therapies (CAR-T cell therapy), liquid biopsies (circulating tumour DNA, circulating tumour cells), patient-derived models (organoids), and murine cancer models.
Available for Honours/Masters/PhD supervision. Contact for available projects.
Cancer
| Project title | Research student |
|---|---|
| Improving the infiltration, persistence, and effector responses of CAR T cells for pancreatic cancer treatment | Oliver LIANG |
| Translational approach to peritoneal malignancy using biomarkers, patient-derived models and novel therapies | Samuel SMITH |
Publications
Expand all
Journals
- Ke, H., Kao, S., van Zandwijk, N., Rasko, J., Yeo, D. (2024). Circulating tumor cell detection may offer earlier diagnosis in patients suspected of asbestos-related lung cancer. Lung Cancer, 192, 107829. [More Information]
- Yeo, D., Kao, S., Gupta, R., Wahlroos, S., Bastian, A., Strauss, H., Klemm, V., Shrestha, P., Ramirez, A., Costandy, L., Grimison, P., Clark, J., Rasko, J., et al (2023). Accurate isolation and detection of circulating tumor cells using enrichment-free multiparametric high resolution imaging. Frontiers in Oncology, 13. [More Information]
- Chu, G., Linton, A., Kao, S., Klebe, S., Adelstein, S., Yeo, D., Rasko, J., Cooper, W. (2023). High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma. Histopathology. [More Information]
show 6 more
Expand all
2024
- Ke, H., Kao, S., van Zandwijk, N., Rasko, J., Yeo, D. (2024). Circulating tumor cell detection may offer earlier diagnosis in patients suspected of asbestos-related lung cancer. Lung Cancer, 192, 107829. [More Information]
2023
- Yeo, D., Kao, S., Gupta, R., Wahlroos, S., Bastian, A., Strauss, H., Klemm, V., Shrestha, P., Ramirez, A., Costandy, L., Grimison, P., Clark, J., Rasko, J., et al (2023). Accurate isolation and detection of circulating tumor cells using enrichment-free multiparametric high resolution imaging. Frontiers in Oncology, 13. [More Information]
- Chu, G., Linton, A., Kao, S., Klebe, S., Adelstein, S., Yeo, D., Rasko, J., Cooper, W. (2023). High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma. Histopathology. [More Information]
2022
- Yeo, D., Bastian, A., Strauss, H., Saxena, P., Grimison, P., Rasko, J. (2022). Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells. International Journal of Molecular Sciences, 23(3), 1671. [More Information]
- Sagnella, S., White, A., Yeo, D., Saxena, P., van Zandwijk, N., Rasko, J. (2022). Locoregional delivery of CAR-T cells in the clinic. Pharmacological Research, 182. [More Information]
- Sharifi Tabar, M., Francis, H., Yeo, D., Bailey, C., Rasko, J. (2022). Mapping oncogenic protein interactions for precision medicine. International Journal of Cancer, 151(1), 2019-07-01 00:00:00. [More Information]
show 1 more
2021
- Castelletti, L., Yeo, D., van Zandwijk, N., Rasko, J. (2021). Anti-Mesothelin CAR T cell therapy for malignant mesothelioma. Biomarker Research, 9(1), 11. [More Information]
- Yeo, D., Castelletti, L., van Zandwijk, N., Rasko, J. (2021). Hitting the Bull's-Eye: Mesothelin's Role as a Biomarker and Therapeutic Target for Malignant Pleural Mesothelioma. Cancers, 13(16), 3932. [More Information]
Selected Grants
2023
- USYD-Glasgow Biomedical Engineering Alliance: Revolutionising Cancer Immunotherapy with Triboelectric Nanogenerator (TENG)-Based Sensor Systems and zMovi High-throughput Cell Avidity Analyser Platform, Ju A, Jing Q, Rasko J, Vassali M, Van Oijen A, Mulvihill D, McGuire H, Li G, Wang Y, He Z, Yeo D, Silavnieks U, Office of Global Engagement/Ignition Grants
2022
- Improving pancreatic cancer management through a simple blood test, Yeo D, Tour de Cure Ltd/Mid Career Researcher Grant
show more